Modafinil, a wakefulness-selling agent, has garnered significant consideration since its approval by the U.S. Food and Drug Administration (FDA) in 1998 for the remedy of narcolepsy, obstructive sleep apnea, and shift work sleep disorder. Through the years, its off-label use…